Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6811)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2018 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang YQ, Cao WJ, Gao YF, Ye J, Zou GZ. Serum interleukin-34 level can be an indicator of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol 2018; 24(12): 1312-1320 [PMID: 29599606 DOI: 10.3748/wjg.v24.i12.1312] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i12/1312.htm |
| Number | Citing Articles |
| 1 |
Liuting Chen, Yang Yu, Ertao Liu, Lian Duan, Dandan Zhu, Jinling Chen, Jia Dai, Yinong Duan. Schistosoma japonicum soluble egg antigen inhibits TNF-α-induced IL-34 expression in hepatic stellate cells. Parasitology Research 2019; 118(2): 551 doi: 10.1007/s00436-018-6165-3
|
| 2 |
Han-Jing Zhangdi, Si-Biao Su, Fei Wang, Zi-Yu Liang, Yu-Dong Yan, Shan-Yu Qin, Hai-Xing Jiang. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World Journal of Gastroenterology 2019; 25(33): 4835-4849 doi: 10.3748/wjg.v25.i33.4835
|
| 3 |
Iva Lelios, Dilay Cansever, Sebastian G. Utz, Wiebke Mildenberger, Sebastian A. Stifter, Melanie Greter. Emerging roles of IL-34 in health and disease. Journal of Experimental Medicine 2020; 217(3) doi: 10.1084/jem.20190290
|
| 4 |
Minggui Lin, Xingyun Liu, Xinhui Zhang, Huimin Wang, Yu Fang, Xiaoting Wu, Anqi Yin, Wanqing Yang, Dong Zhang, Miaomiao Li, Ling Zhang, Songcheng Ying. Sp1 Controls the Basal Level of Interleukin-34 Transcription. Immunological Investigations 2023; 52(2): 224 doi: 10.1080/08820139.2022.2157283
|
| 5 |
Caigui Xiang, Heng Li, Wei Tang. Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases. Pharmacological Research 2023; 187: 106566 doi: 10.1016/j.phrs.2022.106566
|
| 6 |
Jie Wang, Sinan Lin, Jonathan Mark Brown, David van Wagoner, Claudio Fiocchi, Florian Rieder. Novel mechanisms and clinical trial endpoints in intestinal fibrosis*. Immunological Reviews 2021; 302(1): 211 doi: 10.1111/imr.12974
|
| 7 |
Takaya Ebato, Shin Ohta, Munehiro Yamaguchi, Hatsuko Mikuni, Hitoshi Ikeda, Megumi Jinno, Kuniaki Hirai, Yoshito Miyata, Hideki Inoue, Tetsuya Homma, Mayumi Yamamoto, Shintaro Suzuki, Akihiko Tanaka, Hironori Sagara. Interleukin-34 induces pulmonary inflammation in a murine model of lipopolysaccharide-induced acute lung injury. The Showa University Journal of Medical Sciences 2021; 33(4): 124 doi: 10.15369/sujms.33.124
|
| 8 |
Fanyun Kong, Kai Zhou, Ting Zhu, Qi Lian, Yukai Tao, Nan Li, Tao Tu, Yanwei Bi, Xiaoying Yang, Xiucheng Pan, Shibao Li, Hongjuan You, Kuiyang Zheng, Renxian Tang. Interleukin‐34 mediated by hepatitis B virus X protein via CCAAT/enhancer‐binding protein α contributes to the proliferation and migration of hepatoma cells. Cell Proliferation 2019; 52(6) doi: 10.1111/cpr.12703
|
| 9 |
Florian Rieder, Pranab K Mukherjee, William J Massey, Yan Wang, Claudio Fiocchi. Fibrosis in IBD: from pathogenesis to therapeutic targets. Gut 2024; : gutjnl-2023-329963 doi: 10.1136/gutjnl-2023-329963
|
| 10 |
|
| 11 |
Deborah J. Gow, Hilary Jackson, Peter Forsythe, Tim Nuttall, Adam G. Gow, Richard J. Mellanby, David A. Hume. Measurement of serum Interleukin 34 (IL‐34) and correlation with severity and pruritus scores in client‐owned dogs with atopic dermatitis. Veterinary Dermatology 2020; 31(5): 359 doi: 10.1111/vde.12873
|
| 12 |
Muhammad Baghdadi, Yui Umeyama, Naoki Hama, Takuto Kobayashi, Nanumi Han, Haruka Wada, Ken-ichiro Seino. Interleukin-34, a comprehensive review. Journal of Leukocyte Biology 2018; 104(5): 931 doi: 10.1002/JLB.MR1117-457R
|
| 13 |
Eleonora Franzè, Irene Marafini, Edoardo Troncone, Silvia Salvatori, Giovanni Monteleone. Interleukin-34 promotes tumorigenic signals for colon cancer cells. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00636-4
|
| 14 |
Kehui Liu, Yezhou Ding, Yun Wang, Qingqing Zhao, Lei Yan, Jingdong Xie, Yunye Liu, Qing Xie, Wei Cai, Shisan Bao, Hui Wang. Combination of IL-34 and AFP improves the diagnostic value during the development of HBV related hepatocellular carcinoma. Clinical and Experimental Medicine 2022; 23(2): 397 doi: 10.1007/s10238-022-00810-7
|
| 15 |
Kai Yang, Pan Ying, Beibei Sun. Interleukin-34 is more suitable than macrophage colony-stimulating factor for predicting liver significant fibrosis in patients with chronic hepatitis B. Scandinavian Journal of Gastroenterology 2024; 59(1): 78 doi: 10.1080/00365521.2023.2254438
|
| 16 |
Tanjilur Rahman, Ayan Das, Mehedy Hasan Abir, Iqbal Hossain Nafiz, Aar Rafi Mahmud, Md. Rifat Sarker, Talha Bin Emran, Mohammad Mahmudul Hassan. Cytokines and their role as immunotherapeutics and vaccine Adjuvants: The emerging concepts. Cytokine 2023; 169: 156268 doi: 10.1016/j.cyto.2023.156268
|
| 17 |
Prerona Boruah, Nikhita Deka.
Interleukin 34 in Disease Progressions: A Comprehensive Review
. Critical Reviews in Immunology 2023; 43(6): 25 doi: 10.1615/CritRevImmunol.2023050326
|
| 18 |
Se Hwan Mun, Peter Sang Uk Park, Kyung-Hyun Park-Min. The M-CSF receptor in osteoclasts and beyond. Experimental & Molecular Medicine 2020; 52(8): 1239 doi: 10.1038/s12276-020-0484-z
|
| 19 |
Jovani Catalan-Dibene, Laura L. McIntyre, Albert Zlotnik. Interleukin 30 to Interleukin 40. Journal of Interferon & Cytokine Research 2018; 38(10): 423 doi: 10.1089/jir.2018.0089
|
| 20 |
Sittisak Honsawek, Nichaphat Bovornsethanant, Thamonwan Woraruthai, Paisarn Vejchapipat, Wanvisa Udomsinprasert, Yong Poovorawan. Elevated serum IL-34 is correlated with disease severity in patients with biliary atresia following Kasai portoenterostomy. International Immunopharmacology 2024; 127: 111356 doi: 10.1016/j.intimp.2023.111356
|
| 21 |
Yu Noda, Takumi Kawaguchi, Masaaki Korenaga, Sachiyo Yoshio, Sho Komukai, Masahito Nakano, Takashi Niizeki, Hironori Koga, Atsushi Kawaguchi, Tatsuya Kanto, Takuji Torimura. High serum interleukin‐34 level is a predictor of poor prognosis in patients with non‐viral hepatocellular carcinoma. Hepatology Research 2019; 49(9): 1046 doi: 10.1111/hepr.13350
|
| 22 |
Yang Si, Jiwei Zhang, Shisan Bao, Steven G. Wise, Yuli Wang, Yanfang Zhang, Yuhong Tang. IL-32 and IL-34 in hepatocellular carcinoma. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1051113
|
| 23 |
Xuebin Peng, Aiping Tian, Junfeng Li, Yongwu Mao, Ni Jiang, Ting Li, Xiaorong Mao. Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies. Digestive Diseases and Sciences 2022; 67(6): 2627 doi: 10.1007/s10620-021-07049-4
|
| 24 |
Yumin Xu, Yuhan Liu, Zhujun Cao, Lin Wang, Ziqiang Li, Zike Sheng, Wei Cai, Hui Wang, Shisan Bao, Qing Xie. Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study. Digestive and Liver Disease 2019; 51(9): 1323 doi: 10.1016/j.dld.2019.02.009
|
| 25 |
Fadhl Al-Shaebi, Liang Wenzhang, Kamal Hezam, Maged Almezgagi, Lin Wei. Recent insights of the role and signalling pathways of interleukin-34 in liver diseases. International Immunopharmacology 2020; 89: 107023 doi: 10.1016/j.intimp.2020.107023
|